Related Experiment Video

Updated: Aug 18, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

The diagnostic utility of cardiac biomarkers in detecting myocardial infarction

Fred S Apple1, MaryAnn M Murakami

  • 1Clinical Laboratories, Hennepin County Medical Center, 701 Park Avenue, Minneapolis, MN 55415, USA. fred.apple@co.hennepin.mn.us

Clinical Cornerstone
|May 19, 2005
PubMed

Insights

Cardiac troponin assays are crucial for diagnosing myocardial infarction. This review examines guidelines, clinical significance, and analytical performance of cardiac biomarkers for chest pain triage.

Area of Science:

  • Cardiology
  • Biochemistry
  • Clinical Diagnostics

Background:

  • Cardiac biomarkers, such as cardiac troponin, are essential for diagnosing myocardial infarction (MI).
  • These biomarkers are released into circulation following myocardial injury, aiding in patient triage for chest pain.
  • Current diagnostic protocols integrate biomarker analysis with clinical and electrocardiographic findings.

Purpose of the Study:

  • To identify key cardiac biomarkers and review diagnostic guidelines for MI detection.
  • To analyze the clinical significance and challenges of current cardiac biomarker assays.
  • To evaluate the analytical performance of a specific cardiac troponin I immunoassay for MI diagnosis.

Main Methods:

  • Review of recent guidelines from major cardiology and biochemistry societies (ESC, ACC, AHA, NACB).
  • Analysis of relevant studies supporting guideline development.
  • Evaluation of the analytical performance of a chemiluminescent microparticle immunoassay for cardiac troponin I quantification.

Main Results:

  • Cardiac troponin is a standard biomarker for MI diagnosis, integrated into clinical decision-making.
  • Existing assays present analytical challenges impacting diagnostic accuracy.
  • The evaluated ARCHITECT system demonstrated reliable quantitative determination of cardiac troponin I in serum and plasma.

Conclusions:

  • Cardiac biomarkers, particularly troponin, are indispensable in the rapid triage of patients with chest pain.
  • Further optimization of cardiac biomarker assays is needed to address analytical limitations.
  • The ARCHITECT system shows promise for accurate MI diagnosis through quantitative troponin I measurement.

More Related Videos

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease04:41

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...